News Abbott’s Zika blood test approved for emergency use Abbott's test is now the first to receive FDA commercial authorisation in an emergency use setting.
News Abbott builds on needle-free diabetes testing with data shar... Abbott's new smartphone app builds on 'revolutionary' needle-free meter
News Abbott unveils next gen point of care diagnostics Abbott hopes for launch of its Alinity suite later this year.
News Abbott’s needleless diabetes platform as effective as self-m... Study demonstrates a 38% reduction in time spent in hypoglycaemia, compared to traditional self monitoring.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
